Detalhe da pesquisa
1.
Management of malignant pleural mesothelioma: a French multicenter retrospective study (GFPC 0802 study).
BMC Cancer
; 15: 857, 2015 Nov 06.
Artigo
Inglês
| MEDLINE | ID: mdl-26546402
2.
Two biomarker-directed randomized trials in European and Chinese patients with nonsmall-cell lung cancer: the BRCA1-RAP80 Expression Customization (BREC) studies.
Ann Oncol
; 25(11): 2147-2155, 2014 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-25164908
3.
Multicentre phase II study of cisplatin-etoposide chemotherapy for advanced large-cell neuroendocrine lung carcinoma: the GFPC 0302 study.
Ann Oncol
; 24(6): 1548-52, 2013 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-23406729
4.
A multicentre phase II randomised trial of weekly docetaxel/gemcitabine followed by erlotinib on progression, vs the reverse sequence, in elderly patients with advanced non small-cell lung cancer selected with a comprehensive geriatric assessment (the GFPC 0504 study).
Br J Cancer
; 105(8): 1123-30, 2011 Oct 11.
Artigo
Inglês
| MEDLINE | ID: mdl-21934690
5.
[Chronic bronchitis: prevalence and quality of life. Analysis of data from the French Health Interview Survey 2002-2003]. / Bronchite chronique: prévalence et qualité de vie.
Rev Mal Respir
; 26(7): 759-68, 2009 Sep.
Artigo
Francês
| MEDLINE | ID: mdl-19953018
6.
Impact of chronic airflow obstruction in a working population.
Eur Respir J
; 31(6): 1227-33, 2008 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-18216058
7.
[Inhaled corticosteroids in asthma: a medico-economic analysis of clinical trials]. / Les corticoïdes inhalés dans l'asthme: analyse médico-économique des essais cliniques.
Rev Mal Respir
; 25(4): 375-89, 2008 Apr.
Artigo
Francês
| MEDLINE | ID: mdl-18536625
8.
[Economic impact of second- and third-line erlotinib treatment of non small-cell lung cancer]. / Conséquences économiques de l'erlotinib dans le traitement des cancers bronchopulmonaires non à petites cellules.
Rev Mal Respir
; 25(9): 1096-103, 2008 Nov.
Artigo
Francês
| MEDLINE | ID: mdl-19106905
9.
[Stage IV NSCLC. Economic analysis in lung cancers]. / Les analyses économiques des cancers bronchopulmonaires (CBP).
Rev Mal Respir
; 25(8 Pt 2): 3S127-37, 2008 Oct.
Artigo
Francês
| MEDLINE | ID: mdl-18971837
10.
[Age and management decisions in patients with primary lung cancer]. / Age et décision de prise en charge des patients atteints d'un cancer pulmonaire primitif.
Rev Mal Respir
; 25(3): 295-302, 2008 Mar.
Artigo
Francês
| MEDLINE | ID: mdl-18449095
11.
[How to treat the relapse of NSCLC after surgery and chemotherapy? IFTC 0702 randomized phase III study]. / Comment traiter la rechute du CBNPC après une chirurgie et chimiothérapie?
Rev Mal Respir
; 25(1): 91-6, 2008 Jan.
Artigo
Francês
| MEDLINE | ID: mdl-18288059
12.
Patients with non-small-cell lung cancer harbouring a BRAF mutation: a multicentre study exploring clinical characteristics, management, and outcomes in a real-life setting: EXPLORE GFPC 02-14.
Curr Oncol
; 25(5): e398-e402, 2018 10.
Artigo
Inglês
| MEDLINE | ID: mdl-30464690
13.
An open multicenter phase II trial of docetaxel-gemcitabine in Charlson score and performance status (PS) selected elderly patients with stage IIIB pleura/IV non-small-cell lung cancer (NSCLC): the GFPC 02-02a study.
Crit Rev Oncol Hematol
; 64(1): 73-81, 2007 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-17669664
14.
[The payer, the T2A pathway, the physician, the patient: the exemple of thoracic oncology]. / Le financeur, la T2A, le médecin, le patient: l'exemple de la cancérologie thoracique.
Rev Mal Respir
; 24(8 Pt 2): 6S216-21, 2007 Oct.
Artigo
Francês
| MEDLINE | ID: mdl-18235417
15.
Randomized multicentric phase II study of carboplatin/gemcitabine and cisplatin/vinorelbine in advanced non-small cell lung cancer GFPC 99-01 study (Groupe français de pneumo-cancérologie).
Lung Cancer
; 51(1): 105-14, 2006 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-16310886
16.
[Stage IV non-small cell lung cancer. Duration of chemotherapy for locally advanced non small cell lung cancers]. / CBNPC stade IV. Durée optimale de la chimiothérapie initiale des cancers non à petites cellules localement avancés.
Rev Mal Respir
; 23(5 Pt 3): 16S72-16S77, 2006 Nov.
Artigo
Francês
| MEDLINE | ID: mdl-17268340
17.
[Tools for assessing healthcare delivery]. / Les outils de l'évaluation des soins.
Rev Mal Respir
; 23(1 Suppl): 3S47-60, 2006 Feb.
Artigo
Francês
| MEDLINE | ID: mdl-16604014
18.
[Investigation of allergic reactions to platinum salts]. / Exploration d'une allergie aux sels de platine.
Rev Mal Respir
; 23(5 Pt 1): 458-62, 2006 Nov.
Artigo
Francês
| MEDLINE | ID: mdl-17314746
19.
[Economic analysis of home based versus hospital outpatient chemotherapy in stage IV non small cell lung cancer]. / Analyse économique de l'administration d'une chimiothérapie en hospitalisation à domicile (HAD) comparée à l'hospitalisation de jour dans les cancers bronchopulmonaires non à petites cellules de stade IV.
Rev Mal Respir
; 23(3 Pt 1): 255-63, 2006 Jun.
Artigo
Francês
| MEDLINE | ID: mdl-16788526
20.
Impact of Continuing First-Line EGFR Tyrosine Kinase Inhibitor Therapy Beyond RECIST Disease Progression in Patients with Advanced EGFR-Mutated Non-Small-Cell Lung Cancer (NSCLC): Retrospective GFPC 04-13 Study.
Target Oncol
; 11(2): 167-74, 2016 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-26315967